Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Phillips 66
PSX
$81.4B
| $300M | 0.04% |
5,593,093
+450,069
| +9% | +$36.6M |
|
377
Martin Marietta Materials
MLM
$33B
| $300M | 0.04% |
1,583,333
-54,472
| -3% | -$13M |
|
378
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
| $299M | 0.04% |
3,025,410
-190,884
| -6% | -$19.3M |
|
|
BPMC
379
DELISTED
Blueprint Medicines
BPMC
| $299M | 0.04% |
5,107,719
-2,271,471
| -31% | -$146M |
|
380
VeriSign
VRSN
$26.6B
| $298M | 0.04% |
1,656,765
+29,707
| +2% | +$5.84M |
|
381
FirstEnergy
FE
$27.5B
| $298M | 0.04% |
7,442,045
+899,944
| +14% | +$41.8M |
|
382
CBRE Group
CBRE
$42.9B
| $298M | 0.04% |
7,906,853
+399,022
| +5% | +$22M |
|
383
Microchip Technology
MCHP
$46B
| $298M | 0.04% |
8,793,854
-1,412,064
| -14% | -$66.4M |
|
384
Cadence Design Systems
CDNS
$93.4B
| $297M | 0.04% |
4,499,482
+96,208
| +2% | +$6.67M |
|
385
Medtronic
MDT
$112B
| $297M | 0.04% |
3,288,443
-1,042,922
| -24% | -$111M |
|
386
Fortune Brands Innovations
FBIN
$6.06B
| $296M | 0.04% |
7,995,193
+3,541,478
| +80% | +$187M |
|
387
Equifax
EFX
$21.4B
| $295M | 0.04% |
2,469,320
+650,874
| +36% | +$94.7M |
|
388
Motorola Solutions
MSI
$77.4B
| $295M | 0.04% |
2,217,451
-711,803
| -24% | -$119M |
|
389
Extra Space Storage
EXR
$31.6B
| $294M | 0.04% |
3,074,116
-567,508
| -16% | -$59.1M |
|
|
PRNB
390
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $294M | 0.04% |
4,951,265
+33,333
| +0.7% | +$1.94M |
|
391
CRH
CRH
$66.8B
| $294M | 0.04% |
10,937,192
-507,604
| -4% | -$17.4M |
|
392
Raymond James Financial
RJF
$34B
| $290M | 0.04% |
6,893,861
+1,938,099
| +39% | +$109M |
|
393
Americold
COLD
$4.27B
| $290M | 0.04% |
8,527,671
+408,141
| +5% | +$13.7M |
|
394
Wheaton Precious Metals
WPM
$60.9B
| $290M | 0.04% |
10,538,480
+2,063,055
| +24% | +$59.5M |
|
395
CACI
CACI
$14.2B
| $289M | 0.04% |
1,368,536
+323,275
| +31% | +$80.3M |
|
396
RH
RH
$3.71B
| $286M | 0.04% |
2,849,551
| – | – |
|
397
Whirlpool
WHR
$2.82B
| $286M | 0.04% |
3,329,823
+1,371,291
| +70% | +$180M |
|
398
Conagra Brands
CAG
$7.23B
| $285M | 0.04% |
9,704,699
-1,649,727
| -15% | -$49.7M |
|
399
Coherent
COHR
$74.2B
| $284M | 0.04% |
9,968,181
+6,731,218
| +208% | +$219M |
|
|
KRTX
400
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $282M | 0.04% |
3,912,406
+10,493
| +0.3% | +$897K |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.